Abiopharma

Gulfport Energy Expands Core Utica Inventory Through Ohio Lease Sale Acquisitions

Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Wealthfront Corporation (NASDAQ: WLTH)

Silo Pharma SILO Notification

Live Oak Bank Appoints Matthew S. Diffley as Chief Accounting Officer

Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call

AbbVie Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NeoVolta to Participate in Virtual Fireside Chat Hosted by Needham & Company on June 30, 2026

Universal Display Corporation’s Dr. Julie Brown Receives Prestigious IEEE Frederik Philips Award

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request